- Home
- UNH vs LLY Comparison
UNH vs LLY Comparison
Compare UNH & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNH
- LLY
- Stock Information
- Founded
- UNH 1977
- LLY 1876
- Country
- UNH United States
- LLY United States
- Employees
- UNH N/A
- LLY N/A
- Industry
- UNH Medical Specialities
- LLY Biotechnology: Pharmaceutical Preparations
- Sector
- UNH Health Care
- LLY Health Care
- Exchange
- UNH Nasdaq
- LLY Nasdaq
- Market Cap
- UNH 548.3B
- LLY 652.7B
- IPO Year
- UNH 1984
- LLY N/A
- Fundamental
- Price
- UNH $300.73
- LLY $770.36
- Analyst Decision
- UNH Buy
- LLY Strong Buy
- Analyst Count
- UNH 25
- LLY 18
- Target Price
- UNH $447.88
- LLY $1,014.67
- AVG Volume (30 Days)
- UNH 14.3M
- LLY 3.3M
- Earning Date
- UNH 07-29-2025
- LLY 08-07-2025
- Dividend Yield
- UNH 2.94%
- LLY 0.78%
- EPS Growth
- UNH 44.67
- LLY 80.99
- EPS
- UNH 23.82
- LLY 12.29
- Revenue
- UNH $410,057,000,000.00
- LLY $49,003,200,000.00
- Revenue This Year
- UNH $13.44
- LLY $33.05
- Revenue Next Year
- UNH $6.44
- LLY $19.39
- P/E Ratio
- UNH $12.62
- LLY $62.71
- Revenue Growth
- UNH 8.06
- LLY 36.38
- 52 Week Low
- UNH $248.88
- LLY $677.09
- 52 Week High
- UNH $630.73
- LLY $972.53
- Technical
- Relative Strength Index (RSI)
- UNH 36.01
- LLY 48.25
- Support Level
- UNH $304.79
- LLY $755.56
- Resistance Level
- UNH $311.79
- LLY $820.72
- Average True Range (ATR)
- UNH 7.00
- LLY 17.93
- MACD
- UNH 5.00
- LLY 0.61
- Stochastic Oscillator
- UNH 26.81
- LLY 34.59
About UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.